CS215110B2 - Reagent means particularly reagent strip for determination of the uric acid in the body liquids - Google Patents
Reagent means particularly reagent strip for determination of the uric acid in the body liquids Download PDFInfo
- Publication number
- CS215110B2 CS215110B2 CS786315A CS631578A CS215110B2 CS 215110 B2 CS215110 B2 CS 215110B2 CS 786315 A CS786315 A CS 786315A CS 631578 A CS631578 A CS 631578A CS 215110 B2 CS215110 B2 CS 215110B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- uric acid
- reagent
- determination
- test
- radical
- Prior art date
Links
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title claims abstract description 40
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title claims abstract description 40
- 229940116269 uric acid Drugs 0.000 title claims abstract description 40
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 15
- 239000007788 liquid Substances 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 238000004737 colorimetric analysis Methods 0.000 claims abstract description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims abstract description 3
- 210000001124 body fluid Anatomy 0.000 claims abstract description 3
- 239000010839 body fluid Substances 0.000 claims abstract description 3
- 239000000872 buffer Substances 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 239000000080 wetting agent Substances 0.000 claims description 5
- 229920003086 cellulose ether Polymers 0.000 claims description 4
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- 239000002250 absorbent Substances 0.000 claims description 3
- 230000002745 absorbent Effects 0.000 claims description 3
- AVMNFQHJOOYCAP-UHFFFAOYSA-N acetic acid;propanoic acid Chemical compound CC(O)=O.CCC(O)=O AVMNFQHJOOYCAP-UHFFFAOYSA-N 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 229960000878 docusate sodium Drugs 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims description 3
- 229920000151 polyglycol Polymers 0.000 claims description 3
- 239000010695 polyglycol Substances 0.000 claims description 3
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 3
- 239000011118 polyvinyl acetate Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 claims description 3
- GKQHIYSTBXDYNQ-UHFFFAOYSA-M 1-dodecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+]1=CC=CC=C1 GKQHIYSTBXDYNQ-UHFFFAOYSA-M 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- TVACALAUIQMRDF-UHFFFAOYSA-N dodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOP(O)(O)=O TVACALAUIQMRDF-UHFFFAOYSA-N 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000002985 plastic film Substances 0.000 claims 1
- 229920006255 plastic film Polymers 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 7
- 229910052783 alkali metal Inorganic materials 0.000 abstract description 2
- 150000001340 alkali metals Chemical group 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 238000002845 discoloration Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 108010092464 Urate Oxidase Proteins 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000007323 disproportionation reaction Methods 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- -1 for example Chemical compound 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- ONBWNNUYXGJKKD-UHFFFAOYSA-N 1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonic acid;sodium Chemical compound [Na].CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC ONBWNNUYXGJKKD-UHFFFAOYSA-N 0.000 description 1
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical class [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical class [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZGCHATBSUIJLRL-UHFFFAOYSA-N hydrazine sulfate Chemical compound NN.OS(O)(=O)=O ZGCHATBSUIJLRL-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 229910000464 lead oxide Inorganic materials 0.000 description 1
- 229940071264 lithium citrate Drugs 0.000 description 1
- WJSIUCDMWSDDCE-UHFFFAOYSA-K lithium citrate (anhydrous) Chemical compound [Li+].[Li+].[Li+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WJSIUCDMWSDDCE-UHFFFAOYSA-K 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- YEXPOXQUZXUXJW-UHFFFAOYSA-N oxolead Chemical compound [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
- Y10T436/148888—Uric acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772744046 DE2744046A1 (de) | 1977-09-30 | 1977-09-30 | Schnelldiagnosticum zur bestimmung von harnsaeure in koerperfluessigkeiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS215110B2 true CS215110B2 (en) | 1982-07-30 |
Family
ID=6020323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS786315A CS215110B2 (en) | 1977-09-30 | 1978-09-29 | Reagent means particularly reagent strip for determination of the uric acid in the body liquids |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4212844A (de) |
| JP (1) | JPS5463893A (de) |
| AT (1) | AT359655B (de) |
| AU (1) | AU515641B2 (de) |
| BE (1) | BE870755A (de) |
| BR (1) | BR7806408A (de) |
| CA (1) | CA1104042A (de) |
| CS (1) | CS215110B2 (de) |
| DD (1) | DD139030A5 (de) |
| DE (1) | DE2744046A1 (de) |
| DK (1) | DK432378A (de) |
| ES (1) | ES473800A1 (de) |
| FI (1) | FI782914A7 (de) |
| FR (1) | FR2404852A1 (de) |
| GB (1) | GB2005017B (de) |
| GR (1) | GR74887B (de) |
| HU (1) | HU176756B (de) |
| IE (1) | IE47385B1 (de) |
| IL (1) | IL55647A (de) |
| IT (1) | IT1099606B (de) |
| LU (1) | LU80288A1 (de) |
| NL (1) | NL7809690A (de) |
| NO (1) | NO783278L (de) |
| NZ (1) | NZ188514A (de) |
| PT (1) | PT68593A (de) |
| SE (1) | SE7810093L (de) |
| ZA (1) | ZA785416B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8591818B2 (en) * | 2005-04-29 | 2013-11-26 | Gary Bokerman | Gas permeable chemochromic compositions for hydrogen sensing |
| US12566174B2 (en) | 2017-05-11 | 2026-03-03 | The Research Foundation For The State University Of New York | Method and kit for determining the presence of monosodium urate crystals in joint synovial fluid |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL137003C (de) * | 1967-10-14 | |||
| US3528777A (en) * | 1968-09-27 | 1970-09-15 | Hycel Inc | Process and compositions for determination of uric acid in blood serum |
| US3822115A (en) * | 1972-08-30 | 1974-07-02 | Medico Electronic Inc | Method and reagent for uric acid determination |
| US4095948A (en) * | 1973-10-19 | 1978-06-20 | Hoffmann-La Roche Inc. | Determination of uric acid |
| AT347600B (de) * | 1974-11-11 | 1979-01-10 | Wellcome Found | Testeinrichtungen |
| US4072627A (en) * | 1976-08-02 | 1978-02-07 | Pierce Chemical Company | Uric acid determination |
| US4141688A (en) * | 1977-08-11 | 1979-02-27 | Miles Laboratories, Inc. | Composition, device and method for determining reducing agents |
-
1977
- 1977-09-30 DE DE19772744046 patent/DE2744046A1/de not_active Withdrawn
-
1978
- 1978-09-18 US US05/943,518 patent/US4212844A/en not_active Expired - Lifetime
- 1978-09-25 FI FI782914A patent/FI782914A7/fi unknown
- 1978-09-25 ZA ZA00785416A patent/ZA785416B/xx unknown
- 1978-09-25 NL NL7809690A patent/NL7809690A/xx not_active Application Discontinuation
- 1978-09-26 IL IL55647A patent/IL55647A/xx unknown
- 1978-09-26 GB GB7838183A patent/GB2005017B/en not_active Expired
- 1978-09-26 PT PT68593A patent/PT68593A/de unknown
- 1978-09-26 SE SE7810093A patent/SE7810093L/xx unknown
- 1978-09-26 IT IT28103/78A patent/IT1099606B/it active
- 1978-09-26 BE BE190700A patent/BE870755A/xx unknown
- 1978-09-27 LU LU80288A patent/LU80288A1/de unknown
- 1978-09-27 NZ NZ188514A patent/NZ188514A/xx unknown
- 1978-09-27 AU AU40263/78A patent/AU515641B2/en not_active Expired
- 1978-09-27 BR BR7806408A patent/BR7806408A/pt unknown
- 1978-09-28 CA CA312,305A patent/CA1104042A/en not_active Expired
- 1978-09-28 NO NO783278A patent/NO783278L/no unknown
- 1978-09-28 DD DD78208169A patent/DD139030A5/de unknown
- 1978-09-28 JP JP11987778A patent/JPS5463893A/ja active Pending
- 1978-09-29 AT AT704778A patent/AT359655B/de not_active IP Right Cessation
- 1978-09-29 FR FR7827882A patent/FR2404852A1/fr active Granted
- 1978-09-29 HU HU78BO1737A patent/HU176756B/hu unknown
- 1978-09-29 DK DK432378A patent/DK432378A/da not_active Application Discontinuation
- 1978-09-29 ES ES473800A patent/ES473800A1/es not_active Expired
- 1978-09-29 IE IE1954/78A patent/IE47385B1/en unknown
- 1978-09-29 CS CS786315A patent/CS215110B2/cs unknown
-
1981
- 1981-04-22 GR GR57321A patent/GR74887B/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATA704778A (de) | 1980-04-15 |
| GB2005017A (en) | 1979-04-11 |
| US4212844A (en) | 1980-07-15 |
| FR2404852A1 (fr) | 1979-04-27 |
| DK432378A (da) | 1979-03-31 |
| IL55647A (en) | 1982-02-28 |
| DE2744046A1 (de) | 1979-04-12 |
| NZ188514A (en) | 1980-10-24 |
| LU80288A1 (de) | 1980-04-21 |
| IT7828103A0 (it) | 1978-09-26 |
| IT1099606B (it) | 1985-09-18 |
| JPS5463893A (en) | 1979-05-23 |
| IE781954L (en) | 1979-03-30 |
| IL55647A0 (en) | 1978-12-17 |
| BE870755A (fr) | 1979-03-26 |
| DD139030A5 (de) | 1979-12-05 |
| GR74887B (de) | 1984-07-12 |
| NO783278L (no) | 1979-04-02 |
| PT68593A (de) | 1978-10-01 |
| IE47385B1 (en) | 1984-03-07 |
| FI782914A7 (fi) | 1979-03-31 |
| GB2005017B (en) | 1982-03-10 |
| AU4026378A (en) | 1980-04-03 |
| SE7810093L (sv) | 1979-03-31 |
| BR7806408A (pt) | 1979-04-24 |
| AT359655B (de) | 1980-11-25 |
| NL7809690A (nl) | 1979-04-03 |
| FR2404852B1 (de) | 1981-09-11 |
| CA1104042A (en) | 1981-06-30 |
| HU176756B (en) | 1981-05-28 |
| AU515641B2 (en) | 1981-04-16 |
| ZA785416B (en) | 1979-09-26 |
| ES473800A1 (es) | 1979-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5620863A (en) | Blood glucose strip having reduced side reactions | |
| EP0654659B1 (de) | Testvorrichtung mit definiertem Volumen | |
| US6998248B2 (en) | Reagent test strip for analyte determination having a hemolyzing agent | |
| EP0826777B1 (de) | Chemischer Zeitsetzer für einen direktablesbaren Reagenzteststreifen | |
| US4273868A (en) | Color stable glucose test | |
| US5811254A (en) | Broad range total available chlorine test strip | |
| JPH0611447A (ja) | 分析物の分光光度定量分析のための改良酸化カツプリング染料 | |
| HU176045B (en) | Diagnostical composition for determining uric acid | |
| EP0036563B1 (de) | Bilirubinbeständige Zusammensetzung zur Bestimmung von Cholesterin, diese Zusammensetzung enthaltende Probevorrichtung und Verfahren zur Herstellung dieser Probevorrichtung | |
| JPH0266451A (ja) | 尿のイオン強度又は比重を測定する方法、試薬及び試験片 | |
| US4132527A (en) | Diagnostic compositions, diagnosing instruments, and methods of manufacturing same | |
| US5055388A (en) | Process and reagent composition for determination of fructosamine in body fluids | |
| US3971702A (en) | Diagnostic composition for saccharide determination | |
| JP3326831B2 (ja) | 水性液体試料のイオン強度又は比重測定用試薬組成物 | |
| CA1134247A (en) | Bilirubin-resistant determination of uric acid | |
| EP0158964A2 (de) | Testsatz zum Nachweis einer Substanz in einer Körperflüssigkeit | |
| JPH054031B2 (de) | ||
| DE2721942C3 (de) | Vorrichtung zum Aufbereiten einer Meßflüssigkeit zum Einsatz in analytisch optischen Geräten | |
| US4212844A (en) | Rapid diagnostic composition for the determination of uric acid in body fluids | |
| JP3167508B2 (ja) | 無機燐定量用試薬及び乾式分析要素 | |
| US3413197A (en) | Controlled sensitivity galactose test composition and process | |
| US7955563B2 (en) | Methods for applying reactive films containing solids to microporous membranes and membranes produced therefrom | |
| US5955027A (en) | Reagent composition, testing piece, and assay kit | |
| US5223438A (en) | Agent composition for detecting redox reaction | |
| JPH05260994A (ja) | ペルオキシド−ペルオキシダーゼ試験系を使用する唾液中の被検体の検出法 |